drugset / Trial / NCT06044194
Evaluation of the Effect of Liposomal L-Arg and Vit C Integration on Mitochondrial Function in Patients With Heart Failure
Phase 3
Unknown
56 enrolled
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
DAMOR Farmaceutici S.p.a. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Pilot study to assess the effect of L-Arg and Vit C liposomal supplementation on mitochondrial function in patients with heart failure, through analysis of the viability of mitochondria isolated from peripheral blood of mononucleate cells (PBMC).
Timeline
- Start
- 2023-03-21
- Primary completion
- 2024-09-30
- Completion
- 2024-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | L-arginine | Small molecule | 1.66 g | Oral |
| Comparator | Vitamin C | Other / unclassified | 500 mg | Oral |